New radiation method offers hope for Hard-to-Treat gynecologic cancers

NCT ID NCT06644846

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new type of radiation called spatially fractionated radiation therapy for people with cervical cancer or pelvic cancer that has come back. It is for patients who cannot get the usual brachytherapy because of unusual anatomy or large tumors. The goal is to see if this technique can control the tumor while limiting damage to nearby organs. The study will enroll 20 participants and follow them for up to 2 years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
spatially fractionated radiation therapy
What this could lead to
If it works, this could offer a new radiation option for patients with cervical cancer or pelvic recurrence who cannot get standard brachytherapy.
What could go wrong
This is a very small early study with only 20 participants, so results may not apply broadly. The technique is new and long-term side effects are not yet known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • ACTREC Tata Memorial Centre

    RECRUITING

    Navi Mumbai, Maharashtra, 410210, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.